Johnson & Johnson (JNJ) Completes Acquisition of Cougar Biotechnology, Inc. (CGRB.OB) Late-Stage, First-in-Class Prostate Cancer Treatment Strengthens Presence in Oncology
7/10/2009 7:55:23 AM
More...
|
Cougar Biotechnology, Inc. (CGRB.OB) Announces Successful Completion of Johnson & Johnson (JNJ)'s Initial Tender Offer and Commencement of Subsequent Offering Period
7/6/2009 9:27:15 AM
More...
|
Johnson & Johnson (JNJ) (JOBS) Says Review of Cougar Biotechnology, Inc. (CGRB.OB) Deal is Complete
6/18/2009 8:12:17 AM
More...
|
Johnson & Johnson (JNJ) Begins Tender Offer to Acquire Cougar Biotechnology, Inc. (CGRB.OB)
6/5/2009 8:28:04 AM
More...
|
Cougar Biotechnology, Inc. (CGRB.OB)'s Prostate Drug Sees 70% Response in Trials
5/27/2009 7:52:09 AM
More...
|
Johnson & Johnson (JNJ) (JOBS) to Acquire Cougar Biotechnology, Inc. (CGRB.OB) for About $970 Million
5/22/2009 7:17:01 AM
More...
|
Cougar Biotechnology, Inc. (CGRB.OB) Reports First Quarter 2009 Financial Results
5/12/2009 9:27:55 AM
More...
|
Cougar Biotechnology, Inc. (CGRB.OB) to Present at Bank of America (BAC) and Merrill Lynch 2009 Health Care Conference
5/5/2009 9:09:26 AM
More...
|
Cougar Biotechnology, Inc. (CGRB.OB) Initiates Phase III Trial of CB7630 (Abiraterone Acetate) in Chemotherapy-Naïve Castration-Resistant Prostate Cancer Patients
4/29/2009 9:52:45 AM
More...
|
Cougar Biotechnology, Inc. (CGRB.OB) to Present at Citi Biotech Day
3/25/2009 9:59:57 AM
More...
|
|